Ligustrazine hydrochloride Prevents Ferroptosis by Activating the NRF2 Signaling Pathway in a High-Altitude Cerebral Edema Rat Model
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1110 - 1110
Published: Jan. 27, 2025
High-altitude
cerebral
edema
(HACE)
is
a
disorder
caused
by
low
pressure
and
hypoxia
at
high
altitudes.
Nevertheless,
as
of
now,
there
still
scarcity
safe
effective
prevention
treatment
methods.
The
active
component
Ligusticum
Chuanxiong,
namely
Ligustrazine
hydrochloride
(LH),
has
shown
potential
in
the
HACE
due
to
its
anti-inflammatory,
antioxidant,
neuroprotective
effects
nervous
system
disorders.
Consequently,
protective
effect
LH
on
mechanism
need
be
further
explored.
Prior
modeling,
90
male
Sprague-Dawley
rats
were
pretreated
with
different
doses
drugs,
including
(100
mg/kg
50
mg/kg),
dexamethasone
(4
ML385
(30
mg/kg).
Subsequently,
placed
low-pressure
anoxic
chamber
simulating
plateau
environment
establish
rat
model.
mechanisms
elucidated
through
determination
brain
water
content,
HE
staining,
ELISA,
immunofluorescence,
molecular
docking,
dynamics
simulation,
western
blot,
other
techniques.
results
showed,
first
all,
that
pretreatment
can
effectively
reduce
content;
down-regulate
expression
AQP4,
HIF-1α,
VEGF
proteins;
alleviate
damage
tissue
nerve
cells.
Secondly,
compared
group,
significantly
MDA
levels
increase
GSH
SOD
levels.
Additionally,
decreased
inflammatory
factors
IL-1β,
IL-6,
TNF-α;
reduced
total
iron
content
tissue;
increased
ferroptosis-related
proteins
such
SLC7A11,
GPX4,
FTH1;
alleviated
ferroptosis
occurrence.
Molecular
docking
simulations
show
strong
binding
affinity
for
NRF2
signaling.
Western
blot
analysis
confirmed
promotes
translocation
from
cytoplasm
nucleus
activates
signaling
pathway
exert
an
antioxidant
effect.
inhibitor
reverse
anti-oxidative
stress
tissue.
In
summary,
may
have
activating
pathway,
inhibiting
ferroptosis,
resisting
oxidative
stress.
Language: Английский
Top 100 most-cited articles on apoptosis of non-small cell lung cancer over the past two decades: a bibliometrics analysis
Lin Ma,
No information about this author
Jing Zhang,
No information about this author
Zi Dai
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 13, 2025
Background
Recently
there
has
been
an
increasing
number
of
studies
have
explored
apoptosis
mechanisms
in
lung
cancer
(LC).
However,
no
researchers
conducted
a
bibliometric
analysis
the
most
cited
articles
this
field.
Objective
To
examine
top
100
influential
and
publications
on
non-small
cell
(NSCLC)
from
2004
to
2023,
summarizing
research
trends
key
focus
areas.
Methods
This
study
utilized
Web
Science
Core
Database
(WOSCC)
NSCLC
using
keyword
selection
manual
screening
for
article
searches.
Bibliometrix
package
R
software
4.3.1
was
used
generate
distribution
statistics
ten
institutions,
journals
authors.
Citespace6.2.
R6
create
visualization
maps
co-occurrence
clustering.
VOSviewer1.6.19
conduct
cluster
publishing
countries
(regions),
with
data
exported
SCImago
Graphica
geographic
cooperation
analysis.
produced
co-citation
journals,
authors,
references.
Results
From
13316
were
retrieved,
chosen.
These
authored
by
934
individuals
269
institutions
across
18
appeared
45
journals.
Citations
ranged
150
1,389,
median
209.5.
The
2005
2007
(n=13).
leading
authors
identified
as
United
States
(n=60),
Harvard
University
(n=64),
CANCER
RESEARCH
(n=15),
SUN
M
YANG
JS
(n=6).
five
keywords
“expression”,
“activation”,
“apoptosis”,
“pathway”
“gefitinib”.
indicates
that
enhancing
through
circular
RNA
regulation
targeting
Nrf2
signaling
pathway
could
become
recent
years.
Conclusion
Apoptosis
subject
extensive
over
many
years,
particularly
relation
its
role
pathogenesis,
diagnosis,
treatment
NSCLC.
aims
identify
highly
forecast
emerging
trends,
thereby
offering
insights
into
novel
therapeutic
targets
strategies
overcome
drug
resistance.
findings
are
intended
serve
valuable
reference
scholars
engaged
field
study.
Language: Английский